India pain management drugs market is anticipated to grow at a CAGR of 7.25% from 2025 to 2030.
India is one of the major APAC economies with high growth potential in the healthcare sector and the country is also witnessing a steady growth in out-of-pocket expenditure continues to be a major factor shaping the market growth in this country. Likewise, the growing diabetic population in India and increasing obesity among people are pushing up the number of people living with joint pain, thus increasing the demand for pain management drugs. According to the International Diabetes Federation, in 2024, the prevalence rate of diabetes was 10.5% among adults with 89,826,900 total number of cases being recorded.
Furthermore, this country has been witnessing a high incidence of cancer among people of all age groups which is expected to propel demand for pain management drugs. As per the Indian Council of Medical Research, in 2022, the projected number of new cancer cases in the country stood at 1,461,427 and is expected to show constant growth in the coming years. Besides growing chronic diseases, India also holds a high prevalence rate in arthritis and with the country’s growing old-age population the usage of pain management drugs for lower back and joint pain is also anticipated to show progression as such age group is more prone to varied body pain.
According to Niti Ayog’s “Senior Care Reforms in India 2024” report, the elderly population strength is 104 million which accounts for 10% of the country’s total population and is projected to grow up to 19.5% by 2050. The phenomenal aging will impact the health aspects of society thereby creating more dependency on medication for overall health improvement.
Moreover, pain management drugs also play an integral role in post-surgical treatment for minimizing pain and improving recovery. For the past couple of years, the scale of surgical procedures in India has shown progression fuelled by the growing disease prevalence, accidental cases, and emphasis on aesthetic appeal. For instance, as per the International Society of Plastic Surgeons, in 2023, total surgical procedures stood at 531,792 which witnessed a significant 37.1% growth over the number of surgeries conducted in 2022.
Hence, due to these health factors and surgical procedures generic medicines are gaining traction in India. Growing awareness among people regarding the efficacy and safety of generic drugs is increasing their adoption among people, thus positively impacting the revenue of market players to an extent.
India Pain Management Drug Market Segmentation